Subscribe To
ARAY / Accuray (ARAY) Reports Q4 Earnings: What Key Metrics Have to Say
ARAY News
By Seeking Alpha
October 6, 2023
With Chinese Type B Approval In Hand, 'Now Or Never' Approaches For Accuray
Accuray's China JV recently received approval to sell its locally-produced Tomo C rad-onc system for China's Type B market - an opportunity that manag more_horizontal
By Zacks Investment Research
October 5, 2023
Accuray's (ARAY) Tomo C Radiation System Gets Approval in China
Accuray's (ARAY) Tomo C radiation therapy system will enable medical care teams to provide personalized and highly precise treatments. more_horizontal
By Zacks Investment Research
October 3, 2023
Accuray's (ARAY) New Offering to Boost Radiation Treatment Plans
Accuray's (ARAY) latest offering is likely to improve radiation treatment. more_horizontal
By Zacks Investment Research
September 8, 2023
Why Is Accuray (ARAY) Down 15.2% Since Last Earnings Report?
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? more_horizontal
By Seeking Alpha
August 19, 2023
Accuray Incorporated - Impressive Growth As Orders Expands
Accuray Incorporated has shown impressive growth in its share price and revenues, making it an attractive investment opportunity in the healthcare equ more_horizontal
By Zacks Investment Research
August 15, 2023
Accuray's (ARAY) Treatment Options to be Boosted Post FDA's Nod
Accuray's (ARAY) latest regulatory approval is likely to improve breast cancer treatment. more_horizontal
By Zacks Investment Research
August 11, 2023
New Strong Sell Stocks for August 11th
NGLOY, ARAY and BANR have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2023. more_horizontal
By Zacks Investment Research
August 10, 2023
Accuray (ARAY) Q4 Earnings and Revenues Lag Estimates
Accuray (ARAY) reports a solid fiscal fourth quarter top line on the back of robust segmental performances. more_horizontal